- The Impact of SABA over reliance
- Treatment Guidelines including new BTS, NICE, SIGN Nov 24 guidelines
- Managing Asthma patients: putting evidence into practice
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.
By watching this sponsored session, you agree for the sponsor named above to contact you about their products, events and/or services – some of which may be promotional in nature. You can withdraw your consent at any time by contacting privacyrequests@astrazeneca.com. Their privacy policy is here.
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033
If you have any questions, comments or queries or would like to request an appointment with an AstraZeneca representative, you can do so here